To examine the potential regulatory involvement of retroelements in the human genome, we screened the transcribed sequences of GenBank and EST databases with long terminal repeat (LTR) elements derived from different human endogenous retroviruses (HERVs). These screenings detected human transcripts containing LTRs belonging to the HERV-E family fused to the apolipoprotein CI (APOCI) and the endothelin B receptor (EBR) genes. However, both genes are known to have non-LTR (native) promoters. Initial RT-PCR experiments confirmed and authenticated the presence of transcripts from both the native and LTR promoters. Using a 5' RACE protocol, we showed that the alternative transcripts of APOCI and EBR are initiated and promoted by the LTRs. The LTR-APOCI fusion and native APOCI transcripts are present in many of the tissues tested. As expected, we found APOCI preferentially expressed in liver, where ca 15% of the transcripts are derived from the LTR promoter. Transient transfections suggest that the expression is not dependent on the LTR itself, but the presence of the LTR increases activity of the APOCI promoter from both humans and baboons. The native EBR-driven transcripts were also detected in many tissues, whereas the LTR-driven transcripts appear limited to placenta. In contrast to the LTR of APOCI, the EBR LTR promotes a significant proportion of the total EBR transcripts, and transient transfection results indicate that the LTR acts as a strong promoter and enhancer in a placental cell line. This investigation reports two examples where LTR sequences contribute to increased transcription of human genes, and illustrates
INTRODUCTION
A very high proportion of mammalian DNA consists of retroelements that have arisen via RNA reverse transcription and reintegration into the genome (1) . Retroelements are found in most, if not all species, where they have amplified to high copy numbers during evolution (2) . The sheer number of such mobile elements suggests that they affect the host genome, and several observations indicate that retroelements impact on the species in a number of ways by acting as insertional mutagens or contributing regulatory functions to genes (3) . While transposable elements can be harmful to their host, the vast majority of transposable elements present in humans are derived from ancient transpositional events which are fixed in Old World primates. Potential long-term effects of the majority of these elements must be either neutral or beneficial, otherwise they would be eliminated by selection.
Human DNA contains essentially two classes of retrosequences, (i) the non-LTR retroposons represented by LINE and Alu sequences, and (ii) the LTR retroelements in which the ERVs (endogenous retroviruses), solitary LTRs derived from ERVs and other LTR-like sequences fall (4) . Human ERVs (HERVs) are classified into different families based on sequence similarity and monophyletic clustering (5, 6) . The thousands of ERVs and solitary LTRs that are present in human DNA are the result of infections and transposition events during primate evolution. Solitary LTRs are common features in the human genome, and they likely arose from a recombination event between the 5' and 3' LTR of a full-length provirus. Despite their evolutionary age, many ERVs are still transcriptionally active in human cells, where different ERV families show quite different sites and levels of transcription (7) . The LTR and ERV elements are especially interesting in this regard since by guest on http://www.jbc.org/ Downloaded from 4 they naturally possess enhancer, promoter and polyadenylation functions within their LTRs, which likely accounts for differences in transcription of the various HERV families. Besides promoting transcription of retroviral genes, several studies have demonstrated that ERVs and LTRs can assume gene regulatory functions (8) (9) (10) . For example, the paratoid-specific expression of amylase in humans is dependent and under control of an HERV-E element (11) . HERV-E also appears to be involved in the expression of human pleiotrophin in placenta (12) . It has also been demonstrated that a HERV-K LTR encodes the last 67 amino acids of one form of the leptin receptor OBR (13) . These findings indicate that an LTR insertion adjacent to or within a gene could have a variety of effects without destroying gene function. Such new insertions may alter tissue specific gene expression or enhance the general transcription levels of the gene, which could be selectively advantageous.
We are using LTR sequences to study the involvement of retroelements in gene regulation. Specifically, we have searched the EST and transcribed subset of GenBank for chimeric retroviral-gene sequences. Here, we report two human genes that are affected by ERV LTRs, the apolipoprotein C-I (APOCI) gene and the endothelin B receptor (EBR) gene. We show that these two genes use a HERV-E LTR as an alternative promoter, demonstrate the presence of the chimeric transcripts in human tissues, and test the significance of the LTRs at the genomic loci of APOCI and EBR. 
EXPERIMENTAL PROCEDURES

Reverse transcription and PCR amplification
Reverse transcription was done with Superscript II (Gibco-BRL) using the same reaction conditions as described previously (14) . PCR was carried out using 0.1-0.5 volumes of each cDNA (0.1-0.5 µg of the initial RNA) per reaction. RNA samples were either obtained from Clontech or prepared from different sections of placenta, as described previously (15) .
The following primers were used to detect the different transcript forms shown in Table 1 for primer sequences): LTR-APOCI fusion transcript, primers APO-LTR1/APO-Ex1; Native APOCI transcript, primers APO-N/APO-Ex1; LTR-EBR fusion transcript, primers EBR-L1/EBR-Ex1; Native EBR transcript, primers EBR-N/EBR-Ex1. (Fig.5) , the following primer combinations were used: LTR-EBR fusion transcript, primers EBR-L1/EBR-Ex2; Native EBR transcript, primers EBR-N/EBR-Ex2; Total EBR transcript, primers EBREx3/EBR-Ex2. In these experiments, 0.15 volumes cDNA was used in the same PCR profile as described above, but with lower cycling (25-28 cycles) to avoid saturation effects during the amplification. The intensity of the amplification products was by guest on http://www.jbc.org/ Downloaded from 6 measured after 25 cycles from Ethidium Bromide stained gels using the 1D Image Analysis Software (Kodak).
5'-RACE
Placental and brain Marathon-ready cDNA libraries were purchased from Clontech, and 5 µl cDNA library was used in 5'RACE analysis as described in the protocol supplied with the library. The first PCR amplification was performed using EBR exon specific primer (Table 1) EBR-ex4 and the AP1 primer (provided by the supplier), and with the APOCI primer APO-ex1 and primer AP1. The nested PCR was performed by EBR primer EBR-ex5 and the AP2 primer (provided by the supplier), and with the APOCI primer APO-ex2 and AP2. The following temperature profile was used for all amplifications: one initial denaturing at 95 o C for 1 min followed by 35 cycles at 95 o C for 30s, and annealing and extension at 68 o C for 4 min. The 5'-RACE products were cloned using the pGEM-T vector system I (Promega). Clones were selected for sequencing after hybridization using retroviral-specific oligonucleotides APO-LTR1 and EBR-L1 (Table   1) .
Primer extension
The oligonucleotide primer APO-ex3, complementary to exon 3 of APOCI, was Locus specific PCR Locus specific PCR was performed essentially as described previously (16) . The following EBR constructs were made: pEBR-NP, the 5' flanking region of the native EBR transcription initiation site was isolated using primers EBR-NP1K (-1259/-1239) and EBR-NP2B (-208/-187). Digested and purified amplification products were inserted into KpnI/BglII digested pGL3B; pEBR-LTR, the complete LTR was amplified with primers EBR-LTR1K (5'-ggggtaccTAAGGGAGGATACCACC-3')/EBR-LTR2B
(5'-GCAGCTTCTCCTGCTACAagatcttc-3') and inserted into KpnI/BglII digested pGL3B; pEBR-NP+LTR-S and pEBR-NP+LTR-A: these constructs were made by introducing the LTR at a distance of the native promoter region of construct pEBR-NP.
The full LTR was amplified with LTR specific primers, EBR-LTR1Ba (5'-9 cgggatccTAAGGGAGGATACCACC-3')/EBR-LTR2Ba (5'-GCAGCTTCTCCTGCTACAggatcccg-3'). Purifed and BamHI digested amplification products were introduced into the BamHI site of construct pEBR-NP which is located two kb from the KpnI/BglII site on pGL3B. Constructs introduced either in sense (LTR-S) or antisense (LTR-A) with respect to the native EBR promoter region were isolated. The location of the primers was based on the initiation codon at position 1260 of GenBank Accession D13162. The LTR primers were derived from GenBank Accession AL139002.
The following APOCI constructs were made: pAPO-P, the 5' flanking region of the APOCI transcription initiation site was isolated using primers APO-P1K ( hours, the cells were lysed and the luciferase activities were measured using the DualLuciferase Reporter Assay System (Promega) and normalized to the internal control.
Transfections were performed in triplicates, and repeated at least twice.
DNA sequencing
Double stranded plasmid DNAs were sequenced using an ABI PRISM Dye
Terminator Cycle Sequencing Ready Reaction Kit and an ABI 373 sequencer (Perkin Elmer).
RESULTS
Identification and characterization of chimeric transcripts
Using the strategy outlined in Fig.1 , we searched GenBank and the human EST databases using the LTR and the leader region of published HERV elements (7).
Transcripts with only the U3-R part of the LTR and no other HERV sequence likely represent mRNA polyadenylated by the LTR, whereas transcripts with R-U5 or R-U5- To authenticate the presence of fusion transcripts, we synthesized primers corresponding to the retroviral and the gene specific regions of the identified transcripts.
By using this primer combination in RT-PCR it is possible to detect the presence and the relative abundance of the fusion transcripts in human tissues. Both of the genes were previously reported as having a different promoter region, separated from the retroviral LTR (20) (21) (22) . We will refer to these two regions as the "native" APOCI and EBR
promoter. To detect any biases of the LTR and native transcripts, we also used a primer promoted EBR transcript is restricted to placenta, where its levels appear comparable to that of the widely expressed native transcript (Fig.2B ). In the case of APOCI, transcripts from the native promoter in liver were high as expected (20) but are also detectable by PCR in many of the other RNAs tested ( Fig.2A) . Transcripts from the solitary LTR were detected in two distinct forms (see Fig.3A ), both of which were also detected in many all are in the sizes ranging from 400-600 bases, and the resolution in this area of agarose gels is poor. For EBR, the only unique sequence of the LTR-driven transcript is from the retroviral part (Fig.3) and it is not feasible to use this region as a probe because of the repetitive nature of the LTR sequences in human DNA.
We instead performed a primer extension protocol using RNAs from several tissues, and an oligonucleotide derived from exon 3 of APOCI . Using this strategy, we detected transcripts of sizes corresponding to the native and the LTR-driven transcripts.
We only detected transcripts corresponding to the shorter, double spliced APOCI LTRfusion transcript. As expected, the relative level of transcription was highest in liver (Fig.4) , which is the major site of APOCI transcription (20) . By densiotometry, we estimated that the short transcript derived from the LTR promoter represents approximately 15% of the total in liver. Other sites of transcription, for example testis, lung and brain, were also detected using this analysis. However, in these tissues the level of transcription was lower than in liver. We also used a fragment spanning the coding region of APOCI in northern hybridization (not shown). The signal in liver was at least 40-50 times stronger than for any of the other tissues, indicating that the primer extension analysis underestimated the level of APOCI mRNA in liver. A possible explanation of this could be saturation effects in the primer annealing step of the extension protocol, or poor quality of the liver RNA.
To estimate the relative level of the LTR-EBR fusion transcript, we performed a low-cycle PCR protocol. This was done by serial dilution of the input reverse transcribed RNA to avoid saturation effects during amplification. Because the LTR-driven EBR fusion transcript was detected in placenta, we tested RNA prepared from different parts of the placenta in amplifications with primers specific for the native and the LTR-driven transcripts. We also used primers specific for the exons only, which would allow estimation of the total level of EBR mRNA in the different samples (Fig.5) . Depending on the origin of the cDNA used, approximately 50-65% of the total amount of EBR transcripts were estimated by densitometry to be derived from the native promoter, and 25-30% of the total was derived from the LTR promoter. As has been reported previously, we saw no evidence for EBR expression in amnion (26) .
Significance of the HERV-E LTRs in expression of APOCI and EBR
To investigate the significance of the LTR in expression regulation of the APOCI gene, we inserted the native promoter region, which naturally contains the LTR and the native promoter, upstream of a promoter-less luciferase reporter plasmid (pGL3B). We also tested the activity of the LTR by itself, and the native construct where the LTR was is not contributing significantly to the overall expression levels of APOCI in liver.
However, when the LTR is removed from the APOCI locus the promoting activity of the region drops about 40% in HepG2, suggesting that the presence of the LTR in the APOCI locus contributes to the overall activity of the native promoter region. However, we found no evidence that the LTR alone acts as an enhancer in liver cells when positioned at a greater distance from the native promoter.
A test of the effect the LTR had at the time of integration in the primate lineage would be to insert the LTR into the APOCI locus of a species that naturally lacks the LTR. Our analysis showed that all hominoids have the LTR integrated in the APOCI locus, but that it is absent in the baboon. The sequence of APOCI baboon locus has been determined (28) , and sequence alignments of the human and baboon loci verified the absence of the LTR in the baboon (not shown). We inserted the LTR into the baboon APOCI locus at the orthologous site as it is present in the human locus, and compared the relative promoting activity between the constructs with and without the LTR. The LTR insertion into the baboon locus resulted in increased expression, similar to that seen in the human locus, suggesting that the LTR had a similar effect when it first integrated in the primate lineage (Fig.6 ).
To investigate the effect of the LTR in EBR expression, the native EBR promoter region or the LTR alone were inserted upstream of the luciferase gene of pGL3B. We also inserted the LTR at a distance, in direct and opposite orientation with respect to the native EBR promoter region, to test for potential enhancing effect of the LTR on the EBR native promoter region. The choriocarcinoma cell line JEG-3 and the liver cell line
HepG2 were transiently transfected with these constructs, and the results are shown in Fig.7 . In both JEG-3 and HepG2, the activity of the native EBR promoter segment alone is low and it is evident that the native EBR promoter is dependent on an enhancer 
DISCUSSION
In this study, we detected and characterized alternative transcripts of the APOCI and EBR genes with HERV-E sequences at their 5' termini. Both fusion transcripts are expressed in a variety of human tissues, and were shown by 5' RACE to initiate downstream of a putative TATA box within HERV-E LTRs, demonstrating that the LTRs are alternative promoters for these genes in humans. For APOCI, we found that only a minor fraction of transcripts is derived from the LTR promoter in liver. The significance of APOCI in other tissues is not known and the general transcription levels are lower than observed in liver. However, the LTR and native promoters appear to be equally active in many of the other tissues tested.
In the case of EBR, it should be noted that the LTR-EBR fusion transcript was first isolated from a placental library by Arai et al. (29) , but was considered to be a gene rearrangement or artifact due to the LTR in the 5' UTR which differed from the originally described UTR region of EBR (21, 22) . In our 5' RACE of placental cDNA, the major form corresponded to transcripts sizes derived from the native promoter, demonstrating that this is the most abundant transcript form in placenta. However, the semi-quantitative RT-PCR analysis using cDNA derived from different parts of the placenta indicated that 25-30% of the total was derived from the LTR promoter, depending on the placental cDNA used. In decidua and chorion, the total level of amplified EBR was estimated to be higher than was seen for the LTR and native derived amplification products combined which could be accounted for by the minor EDNRB∆ forms (see Results), because these transcripts are also expressed in placenta (23) . Table 1 . Expected amplification product sizes were obtained for the different primer combinations. The numbers to the left are sizes of the DNA markers. 
